13F

Stock

Acrivon Therapeutics, Inc.

ACRV · held by 2 managers

Reported value

$95K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$183.1K

Price effect on 2 books still in the name

Largest holder

$66.4K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC32.7K$66.4K−$130.5KCut−$162.9K
Marex Group plc14.1K$28.6K−$52.6KCut−$50.8K

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.